Cargando…
Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance
Ferroptosis, a recently identified form of regulated cell death characterized by the iron-dependent accumulation of lethal lipid peroxidation, has gained increasing attention in cancer therapy. Ferroptosis suppressor protein 1 (FSP1), an NAD(P)H-ubiquinone oxidoreductase that reduces ubiquinone to u...
Autores principales: | Lee, Jaewang, Roh, Jong-Lyel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295722/ https://www.ncbi.nlm.nih.gov/pubmed/37371948 http://dx.doi.org/10.3390/antiox12061218 |
Ejemplares similares
-
Targeting Iron-Sulfur Clusters in Cancer: Opportunities and Challenges for Ferroptosis-Based Therapy
por: Lee, Jaewang, et al.
Publicado: (2023) -
SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
por: Lee, Jaewang, et al.
Publicado: (2022) -
Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis
por: Lee, Jaewang, et al.
Publicado: (2020) -
Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer
por: Lee, Jaewang, et al.
Publicado: (2022) -
PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells
por: You, Ji Hyeon, et al.
Publicado: (2021)